Drug firm Cadila Healthcare, India, has signed a technology agreement with Pharm Aid Ltd., Russia, for production of varicella vaccine used to prevent virus causing chickenpox. Through this agreement, Zydus Cadila (group firm) gains access to public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakhstan, Armenia and Kyrgyzstan. The agreement will bring together local manufacturing, distribution and managerial capabilities of the companies.
The company said that it aims to bring in a continuous supply of vaccines which could be included in the critical childhood immunization programme. The estimated demand for vaccines is 3 million doses per annum in the Russian Federation alone. Pharm Aid Ltd., a joint venture between Russian National Immunobiological Company (Nacimbio) and Ishvan Pharmaceutical, UAE, has been set up for localisation of vaccine production in Russia.
Title
Pact to produce chickenpox vaccine
VATIS UPDATE Part
Article body